The US, South Africa, and the EU will temporarily stop the rollout of the Johnson & Johnson covid-19 jab, after reports of rare blood clotting.
As a result, J&J has paused its EU rollout which started this week.
One company’s loss is another company’s gain as Pfizer has ramped up production of its vaccine, and will be able to deliver a total of 300 million doses to the US in July.
Will we see a vast turnaround in Pfizer’s price action?
- JNJ 02:45
- PFE 04:10